| Male Reproductive Health Studies | Lifetime | 10 | IN 2 | 99.21 |
| Sperm and Testicular Function | Lifetime | 117 | IN 3 | 99.31 |
| Hormonal and reproductive studies | Lifetime | 236 | IN 3 | 98.61 |
| Reproductive Health and Technologies | Lifetime | 140 | IN 3 | 98.58 |
| Sexual function and dysfunction studies | Lifetime | 121 | IN 3 | 98.37 |
| Sexual Differentiation and Disorders | Lifetime | 179 | IN 4 | 98.44 |
| COVID-19 Impact on Reproduction | Lifetime | 135 | IN 2 | 96.41 |
| Reproductive Biology and Fertility | Lifetime | 659 | IN 3 | 98.12 |
| Testicular diseases and treatments | Lifetime | 224 | IN 2 | 97.36 |
| Pharmacology and Obesity Treatment | Lifetime | 265 | IN 3 | 97.02 |
| Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities | Lifetime | 400 | IN 4 | 96.69 |
| Urinary Bladder and Prostate Research | Lifetime | 628 | IN 3 | 97.08 |
| Genital Health and Disease | Lifetime | 418 | IN 3 | 96.55 |
| Sexual function and dysfunction studies | 2021-2025 | 3 | IN 1 | 99.38 |
| Hormonal and reproductive studies | 2021-2025 | 6 | IN 1 | 99.22 |
| Male Reproductive Health Studies | 2021-2025 | 3 | IN 1 | 98.33 |
| Sexual Differentiation and Disorders | 2021-2025 | 12 | IN 1 | 98.50 |
| Genital Health and Disease | 2021-2025 | 26 | IN 1 | 97.23 |
| COVID-19 Impact on Reproduction | 2021-2025 | 57 | IN 1 | 97.29 |
| Urinary Bladder and Prostate Research | 2021-2025 | 50 | IN 1 | 97.69 |
| Sperm and Testicular Function | 2021-2025 | 70 | IN 6 | 97.37 |
| Reproductive Health and Technologies | 2021-2025 | 127 | IN 2 | 94.44 |
| Reproductive Biology and Fertility | 2021-2025 | 520 | IN 12 | 92.93 |
| COVID-19 and healthcare impacts | 2021-2025 | 934 | IN 17 | 89.02 |
| Pharmacology and Obesity Treatment | 2021-2025 | 109 | IN 3 | 91.51 |
| Urologic and reproductive health conditions | 2021-2025 | 252 | IN 7 | 87.85 |
| Urological Disorders and Treatments | 2021-2025 | 703 | IN 17 | 86.17 |
| Sexuality, Behavior, and Technology | 2021-2025 | 314 | IN 3 | 85.87 |
| Ovarian function and disorders | 2021-2025 | 767 | IN 23 | 85.19 |
| Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities | 2021-2025 | 996 | IN 12 | 65.79 |
| Pharmacological Effects and Assays | 2021-2025 | 292 | IN 9 | 64.19 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 591 | IN 4 | 62.03 |
| Testicular diseases and treatments | 2021-2025 | 838 | IN 18 | 61.68 |
| Doping in Sports | 2021-2025 | 287 | IN 3 | 45.86 |
| Hypothalamic control of reproductive hormones | 2021-2025 | 909 | IN 32 | 41.53 |
